Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 200 of 463 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/31/17
End: 01/31/20
Due: 01/31/21
Phase: N/A
Priority: Normal
Start: 12/31/15
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 03/31/14
End: 12/31/19
Due: 12/31/20
Phase: N/A
Priority: Normal
Start: 05/01/22
End: 05/31/24
Due: 05/31/25
Phase: N/A
Priority: Normal
Start: 08/02/16
End: 01/26/17
Due: 01/26/18
Phase: N/A
Priority: Normal
Start: 10/01/20
End: 10/01/21
Due: 10/01/22
Phase: N/A
Priority: Normal
Start: 04/01/24
End: 12/31/29
Due: 12/31/30
Phase: N/A
Priority: Normal
Start: 02/28/14
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 12/31/13
End: 12/31/15
Due: 12/31/16
Phase: N/A
Priority: Normal
Start: 02/28/09
End: 05/31/11
Due: 05/31/12
Phase: N/A
Priority: Normal
Start: 10/01/18
End: 12/01/20
Due: 12/01/21
Phase: N/A
Priority: Normal
Start: 12/31/12
End: 06/30/18
Due: 06/30/19
Phase: N/A
Priority: Normal
Start: 08/15/17
End: 07/14/20
Due: 07/14/21
Phase: N/A
Priority: Normal
Start: 10/31/15
End: 11/30/18
Due: 11/30/19
Phase: N/A
Priority: Normal
Start: 06/01/19
End: 06/01/21
Due: 06/01/22
Phase: N/A
Priority: Normal
Start: 06/20/25
End: 12/01/30
Due: 12/01/31
Phase: N/A
Priority: Normal
Start: 08/15/20
End: 10/31/21
Due: 10/31/22
Phase: N/A
Priority: Normal
Start: 04/03/23
End: 01/01/28
Due: 01/01/29
Study of Chidamide, Decitabine and Immune Checkpoint Inhibitors in R/R NHL and Advanced Solid Tumors
Phase: N/A
Priority: Normal
Start: 03/30/22
End: 04/01/25
Due: 04/01/26
Phase: N/A
Priority: Normal
Start: 06/01/24
End: 06/01/27
Due: 06/01/28
Phase: N/A
Priority: Normal
Start: 12/08/22
End: 12/08/24
Due: 12/08/25
Phase: N/A
Priority: Normal
Start: 01/01/14
End: 10/01/17
Due: 10/01/18
Phase: N/A
Priority: Normal
Start: 09/01/24
End: 12/01/25
Due: 12/01/26
Phase: N/A
Priority: Normal
Start: 01/31/16
End: 01/31/19
Due: 01/31/20
Phase: N/A
Priority: Normal
Start: 04/01/22
End: 12/30/22
Due: 12/30/23